In particular, two of these ZFGs, ESR1, and ZNF132, showed a significantly higher diagnostic capability than SEPT9, suggesting that they might be promising biomarkers for CRC diagnosis, especially for KRAS mutated patients. Here, ESR1 is linked to colorectal carcinoma.